What is Allm?
Allm Inc. operates at the intersection of healthcare and mobile technology, championing the corporate philosophy of Shaping Healthcare. The company is best known for its flagship application, Join, which facilitates seamless communication and data exchange among medical professionals. By providing robust ICT infrastructure, Allm addresses the complexities of modern medical care, ensuring that clinical teams can collaborate effectively across borders. As a Japan-originated enterprise, Allm is currently scaling its operations to provide scalable, high-impact solutions to international markets, effectively bridging the gap between traditional medical practices and modern digital efficiency.
How much funding has Allm raised?
Allm has raised a total of $230M across 2 funding rounds:
Series A
$50M
Share Placement
$180M
Series A (2021): $50M with participation from Koninklijke Philips N.V. and Mitsui & Co.
Share Placement (2022): $180M led by DeNA North America and Seibu Realty Solutions
Key Investors in Allm
Mitsui & Co.
Mitsui & Co. is a global trading and investment company that leverages its vast cross-industry network to foster sustainable growth, with a specific strategic focus on enhancing healthcare access and quality of life.
DeNA North America
DeNA is a Tokyo-based technology conglomerate that develops diverse mobile and online services, utilizing its expertise in AI and internet-based platforms to drive innovation in the healthcare and entertainment sectors.
Koninklijke Philips N.V.
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum, from healthy living and prevention to diagnosis, treatment, and home care.
What's next for Allm?
With the recent infusion of $180M, Allm is poised to deepen its penetration into global healthcare markets. The strategic roadmap focuses on enhancing the Join platform's capabilities, integrating advanced AI-driven diagnostics, and expanding its footprint in regions where medical infrastructure requires modernization. By leveraging the expertise of its diverse investor base, Allm is well-positioned to navigate the regulatory and operational challenges of international healthcare expansion. The company's focus remains on long-term value creation, aiming to standardize high-quality medical communication and improve patient outcomes on a global scale through its specialized ICT ecosystem.
See full Allm company page
